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HAEMODYNAMIC RESPONSE TO TENS APPLIED TO THE
UPPER THORACIC NERVE ROOTS IN NORMAL SUBJECTS
Jennifer C. Nitz, PhD
Abstract: This study investigated the haemodynamic response to the 90-minute application of 85 Hz
transcutaneous electrical nerve stimulation (TENS) to the T1 and T5 nerve roots. Comparison was made between
20 healthy subjects who had TENS stimulation and a separate group of 20 healthy subjects who rested for
90 minutes. Pulse and blood pressure were measured just prior to the start of TENS stimulation, after 30 minutes
of stimulation, and after 90 minutes of stimulation (immediately after stopping TENS) or at completion of the
rest time depending on group allocation. The rate pressure product was calculated from the pulse and systolic
blood pressure data. Multivariate repeated measures analysis showed a significant group effect for TENS (p =
0.048). Univariate repeated measures analyses showed a significant group by time effect due to TENS on systolic
blood pressure over the 90-minute time period (p = 0.028). Separate group repeated measures ANOVA showed
a significant decline in heart rate (p = 0.000), systolic blood pressure (p = 0.013) and rate pressure product
(p = 0.000) for the TENS group, while the control resting group showed a significant decline in heart rate only
(p = 0.04). The application of 85 Hz TENS to the upper thoracic nerve roots causes no adverse haemodynamic
effects in healthy subjects.
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Introduction
Transcutaneous electrical nerve stimulation (TENS) has
been used for the management of pain for a number of
decades. How TENS affects pain continues to be
investigated. Paramount to these studies is the
understanding of the complexity of pain as well as the
variable parameters employed when applying TENS to
treat pain. Considering these variables, a variety of
neurological, histochemical and neuropharmacological
responses have been demonstrated that might be
attributed to TENS [1]. These responses have been
considered to be responsible for the modulation of the
pain perceived by the patient [2].
The rationale for site of electrode application for
TENS varies depending on the study. Usually, TENS is
delivered via electrodes placed over the area of perceived
pain, the nerve trunk or nerve roots supplying the
Research Report
painful area, or on the corresponding segment on the
opposite side of the body, as has been used in the
treatment of phantom limb pain [3]. The sensory stimulus
is conveyed to the spinal cord via the afferent neural
input where local and central transmission continues.
The effect on pain pathways has been investigated and
continues to be of interest, but very little study of the
vascular haemodynamic response to TENS has been
reported [4–8]. The effect of high frequency TENS on
some autonomic responses mediated by the sympathetic
nervous system was investigated by Sanderson et al [7].
They found that raised diastolic blood pressure (DBP)
during hand-grip was significantly reduced by applying
TENS. When TENS was applied during other known
effectors of autonomic responses such as the Valsalva
manoeuvre, no significant effect on heart rate or blood
pressure (BP) was produced. From these results,
Sanderson et al concluded that TENS stimulation had a
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mild inhibitory action on sympathetic activity [7].
There have been some studies of the effect of TENS
on peripheral circulation in healthy volunteers. Upper
limb stimulation with high (100 Hz) and low frequency
(4 Hz and 2 Hz) TENS was studied by Hardy [9] and
Scudds et al [10] who utilized thermography of the hand
to determine the effect of stimulation. The effect of high
frequency (110 Hz) TENS to the common peroneal
nerve and the tibial nerve on ipsilateral calf blood flow
was investigated by Indergand and Morgan [11]. The
studies by Indergand and Morgan [11] and Scudds et al
[10] revealed that high frequency TENS did not alter calf
blood flow or finger temperature. However, Hardy [9]
showed some decrease in skin temperature due to high
frequency (100 Hz) stimulation. Because this effect was
reversed by sympathetic block, he claimed the response
to be sympathomimetic. Both studies of the effect of low
frequency stimulation showed inconsistent results in
participants, so no conclusions regarding mode of action
were claimed.
Physiotherapists commonly add TENS to their
treatment regimes for pain from arthritis and osteoporosis.
When these causes of pain emanate from the upper
thoracic vertebrae, local TENS application is considered.
A source of pain not commonly treated with TENS is
cardiac pain or angina. Cardiac pain is caused by ischaemia
of cardiac tissues. Myocardial ischaemia increases the
sensory nerve activity in the adventitia of the coronary
arteries, myocardium and subepicardial tissue, and pain
receptors may be stimulated by metabolites associated
with ischaemia [12]. The sensory and pain afferent
impulses from the heart are transmitted to the central
nervous system (CNS) via fibres in the cervical and
thoracic sympathetic nerves. These reach the spinal cord
via the upper four or five thoracic dorsal nerve roots [5].
Angina pain is considered to increase the level of pain by
increasing myocardial ischaemia through stimulation of
increased sympathetic activity [13].
TENS usage in the management of pain of cardiac
origin has only received minimal attention. There have
been several clinical trials reporting the effect of TENS on
angina [5, 6, 12, 14]. The mechanism of this action is still
being studied, although there have been no recent
communications regarding this method of cardiac pain
management. When TENS is used to manage cardiac
pain, it not only works in the expected pain-relieving
manner, but also appears to suppress sympathetic activity
as revealed by a drop in systolic blood pressure (SBP) and
heart rate [5, 6, 12, 14]. The rate pressure product (RPP)
is calculated from the pulse rate (PR) and SBP and is
considered an easy method of measuring myocardial
oxygen consumption [8, 15, 16]. The decrease in the RPP
induced by TENS applied at rest in subjects with angina
[6] and during exercise [8] supports the inference that
high frequency TENS suppresses sympathetic activity.
The question arises as to whether people with no
cardiac pathology demonstrate a decrease in SBP, PR
and RPP from TENS that has been seen in patients with
chronic angina [6, 14]. The aim of this study was to
measure the haemodynamic response when TENS is
applied to the upper thoracic nerve roots of healthy
subjects. The changes in the haemodynamic variables of
PR, SBP, DBP and RPP were evaluated.
Methods
Subjects
Forty subjects, 29 women and 11 men, were recruited
from the community or the staff and student body at The
University of Queensland, Australia. Subjects were
excluded from the study if they had any known medical
condition such as ischaemic heart disease, peripheral
vascular disease or vasospastic disorders that could affect
cardiovascular responses. Subjects were randomly
allocated to the control (no TENS) group or the TENS
group. The control group ranged in age from 22 to 74
years, with a mean (± standard deviation, SD) age of
38.6 ± 14.2 years. The TENS group ranged in age from 21
to 57 years, with a mean age of 36.7 ± 12.5 years.
Procedure
TENS was applied via four silicone rubber electrodes
positioned paraspinally adjacent but 2 cm lateral to the
spinous processes of T1 and T5, one channel on each
side. The TENS apparatus (Seal SystemsTM Stimulator,
Seal Systems, Australia) delivered a biphasic
exponentially decaying spike wave form of stimulation
with a pulse width of 0.8 milliseconds and a rate of 85 Hz.
The measurements of pulse and BP were taken using a
digital BP and pulse monitor (Oto Biocare Products,
wrist type digital blood pressure monitor BP-800, Japan).
The control group was evaluated while resting in a
chair and receiving no TENS intervention. TENS was
applied under the same conditions to the intervention
group. All subjects were positioned in a normal chair
during the testing period. Their feet were supported on
the floor and the chair back was reclined at about 10
degrees from the upright but supplied lumbar and some
thoracic but not head support. Subjects in each group
were allowed to read or work at a computer during this
time. Pulse and BP were recorded for each group member
at 0, 30 and 90 minutes. In the TENS group, the TENS
electrodes were applied, and then the pulse and BP were
measured immediately before stimulation commenced.
The intensity of stimulation was raised to a level that was
considered to be comfortable by the subject, and which
was then unaltered during the 90 minutes of stimulation.
Pulse and BP were recorded again 30 minutes after the
start of stimulation and immediately after stimulation
was stopped at 90 minutes. The RPP was calculated. All
testing was done in an air-conditioned room to control for
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the effect of temperature and humidity on pulse and BP.
Reliability of the measurements was tested with four
normal subjects. Pulse and BP measurements were taken
on three occasions at the same time intervals as the study
method. The first of each of the two repeat sessions
measured pulse and BP when resting, and no TENS was
given to see if the measurements were reliably stable,
and then repeated at a later time with TENS application.
The second session repeated the first session on another
day. The reliability of the response to TENS was evaluated
in a test–retest manner.
Statistical analysis
Test–retest reliability was examined using intra-class
correlation (ICC) analysis. Repeated measures
multivariate analysis of covariance (MANCOVA) was
used to test group differences. Age was considered as a
covariant. Further repeated measures analysis of variance
(ANOVA) was applied to data from each group to
determine change over time due to resting or TENS.
SPSS version 11.0 (SPSS Inc, Chicago, IL, USA) for
Windows was used for all statistical calculations.
Results
The ICC results for test–retest reliability for pulse, BP and
RPP measurements for the resting (no TENS) and TENS
conditions using the study protocol were acceptable
(ICC > 0.86) [17].
On initial analysis for normality of the data, two
outliers were identified (one in each group). These
subjects were excluded from further analyses as they had
been playing computer games during the test period and
this might have accounted for the difference. Thus,
results from 38 subjects were analysed.
Multivariate analysis of the dependent variables PR,
SBP, DBP and RPP showed a significant within subject
group effect (F = 2.301, p = 0.048). There was no effect
for age. Post hoc repeated measures univariate analyses
showed that SBP had a significant group by time effect
(F = 3.77, p = 0.028) over the 90-minute time period
between the resting and TENS groups. There was also a
trend for a similar group by time effect for RPP (F = 2.406,
p = 0.097). Neither the PR (F = 0.114, p = 0.892) nor DBP
(F = 1.200, p = 0.307) showed any differences between
groups over time.
Examination of the separate groups using descriptive
statistics and repeated measures ANOVA indicated a
significant decline in PR for both groups, a significant
decline in SBP and RPP for the TENS group and a
relatively steady DBP for both groups (Table).
Discussion
The hypothesis that TENS application in the manner
used in this study would cause a change in PR, BP and
RPP in normal subjects was supported only by a significant
difference between the groups for a decrease in SBP. The
possibility of the resting status affecting measurements
during TENS application was considered by comparing
the results from the TENS study group to a group that
rested but did not receive stimulation. The resting group
Table. Descriptive statistics and within-group repeated measures analysis of variance results for the control and
TENS groups
Time
0 min, 30 min after 90 min, p
before TENS starting TENS at cessation of TENS (within group)
Pulse rate
  TENS 72.68 ± 11.9 70.32 ± 10.9 67.95 ± 9.1 0.000
  Control 77.53 ± 10.8 76.05 ± 10.7 73.37 ± 11.6 0.040
SBP
  TENS 117.58 ± 10.5 114.74 ± 10.3 113.05 ± 12.5 0.013
  Control 118.63 ± 16.6 120.68 ± 16.3 120.05 ± 16.2 0.511
DBP
  TENS 70.58 ± 6.3 72.00 ± 6.7 72.94 ± 5.7 0.237
  Control 74.05 ± 8.4 72.58 ± 10.9 74.68 ± 8.7 0.254
RPP
  TENS 8,567.2 ± 1,769.9 8,070.4 ± 1,485.7 7,673.2 ± 1,337.4 0.000
  Control 9,101.8 ± 1,363.3 9,156.8 ± 1,624.1 8,717.2 ± 1,540.4 0.118
TENS = transcutaneous electrical nerve stimulation; SBP = systolic blood pressure; DBP = diastolic blood pressure; RPP = rate pressure product.
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demonstrated some haemodynamic changes, mainly
represented by a significant decline in PR over the 90-
minute time period during assessment. There was no
significant change in DBP in the TENS and control
groups. The change in SBP was significantly different
between the control subjects and those receiving TENS.
The group receiving TENS showed significant (within
group) decreases in PR, SBP and RPP. From these results,
it can be assumed that TENS was responsible for the
significant difference in SBP response between the two
groups of normal subjects.
The implications of these findings are far reaching.
Physiotherapists and other medical workers are often
concerned by possible detrimental effects to the patient
when using TENS in areas that might affect neural
control of cardiac function. These results indicate that
TENS applied at 85 Hz in the area of the upper thoracic
nerve roots had no dramatic haemodynamic effect that
might prove unsafe for healthy patients. Apart from
using TENS in the management of chronic angina pectoris,
where it has been shown to be effective [5, 6, 12, 14],
joint pain or osteoporotic bone pain arising from these
vertebral levels could be treated using a similar TENS
application. Practitioners are urged to use caution when
cardiac pacemakers are used by patients as the electrical
stimulation might interrupt pacing.
There remains the question of how peripheral
sympathetic responses are manifest during TENS
application to the upper thoracic nerve roots. Although
no detrimental responses were observed clinically, the
possibility that these responses might not be desirable
needs further investigation. It is possible that upper limb
cutaneous vasodilatation occurs when the cervical spinal
cord is directly stimulated, as has been demonstrated by
Claeys [18]. Additionally, an increase in ipsilateral hand
temperature after peripheral TENS stimulation at the
wrist level [10] and over the median nerve in the
forearm [9] has been demonstrated. Such responses
should not be detrimental; however, this supposition
needs verification through further study of haemo-
dynamic upper limb responses to TENS applied at the
nerve root level.
Conclusion
The application of 85 Hz TENS bilaterally to the T1 and
T5 nerve roots caused a significant decline in PR, SBP
and RPP during stimulation in healthy subjects between
the ages of 21 and 57 years. The study results indicate
that 85 Hz TENS should be safe to apply in the region of
the upper thoracic nerve roots in healthy people for the
relief of pain from musculoskeletal conditions such as
osteoarthritis and osteoporosis that might affect this part
of the body.
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